<DOC>
	<DOCNO>NCT00731523</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics FTY720 metabolites patient severe renal insufficiency match , healthy volunteer . This study allow good understanding effect renal insufficiency disposition FTY720 .</brief_summary>
	<brief_title>Pharmacokinetics ( PK ) Metabolism FTY720 Patients With Severe Renal Impairment Healthy Matched Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Healthy Subjects : Subjects must calculate glomerular filtration rate ( GFR ) CockcroftGault Equation â‰¥80 mL/min . Severe Renal Impaired Patients : Patients dialysis severe renal failure creatinine clearance &lt; 30 mL/min determine CockcroftGault Equation . Renal function stable within 3 month prior study start . Patients diabetes and/or hypertension otherwise good health may include . However patient diabetes must clinical evidence gastropathy enteropathy . All Subjects/Patients : History multiple recur allergy allergy investigational compound/compound class use study History retinal macular edema . History significant cardiovascular event myocardia infarction , valvular disease , angina , ischemic heart disease , dilate cardiomyopathy , dysrhythmia . History immunocompromise , include positive HIV ( ELISA Western blot ) test result . Severe Renal Impaired Patients : Use highly potent CYP3A4 inhibitor ( e.g . erythromycin , ketoconazole , itraconazole ) within 2 week prior dose . Use beta blocker therapy within two ( 2 ) week prior dose . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>FTY720 , Pharmacokinetics , Renal insufficiency</keyword>
</DOC>